Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in advanced dermatofibrosarcoma protuberans
NCT01059656Phase 2Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in dermatofibrosarcoma protuberans (DFSP), sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2010; status: terminated.
02
Drugs
pazopanib
03
Conditions
dermatofibrosarcoma protuberans (DFSP)
Beyond the preview
Go deeper on NCT01059656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059656.